Physician profile
Joni W Hougaard
NPI 1508801606
$10,430.94
in general payments reported to CMS, 2019-2025
67 companies · $1,439 in 2025
The $1,439 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,037 · 2020: $780 · 2021: $1,807 · 2022: $1,670 · 2023: $1,900 · 2024: $1,797 · 2025: $1,439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,135.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,340.11 | 2021-2025 | |
| Amgen INC. | $879.92 | 2019-2025 | Evenity, Prolia, Repatha |
| Astrazeneca Pharmaceuticals LP | $865.07 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Astellas Pharma US INC | $783.80 | 2019-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $499.64 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $464.48 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Pfizer INC. | $457.75 | 2019-2025 | |
| Lilly USA, LLC | $386.02 | 2019-2025 | Mounjaro, Jardiance, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $362.34 | 2019-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $340.28 | 2019-2024 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Abbott Laboratories | $309.22 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Janssen Pharmaceuticals, INC | $263.51 | 2019-2025 | Spravato |
| Gilead Sciences, INC. | $253.04 | 2021-2025 | |
| Axsome Therapeutics, INC. | $203.71 | 2022-2025 | Sunosi, Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $203.40 | 2022-2025 |
Show all 67 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joni Hougaard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.